Mesoblast (MESO) Operating Income (2016 - 2023)
Historic Operating Income for Mesoblast (MESO) over the last 9 years, with Q2 2023 value amounting to $3.0 billion.
- Mesoblast's Operating Income rose 36.0% to $3.0 billion in Q2 2023 from the same period last year, while for Jun 2023 it was $687.7 million, marking a year-over-year increase of 542984.08%. This contributed to the annual value of -$62.0 million for FY2025, which is 553.46% down from last year.
- Latest data reveals that Mesoblast reported Operating Income of $3.0 billion as of Q2 2023, which was up 36.0% from -$1.2 billion recorded in Q1 2023.
- In the past 5 years, Mesoblast's Operating Income registered a high of $7.0 billion during Q2 2021, and its lowest value of -$1.6 billion during Q1 2021.
- Its 5-year average for Operating Income is $298.4 million, with a median of -$541.9 million in 2019.
- In the last 5 years, Mesoblast's Operating Income surged by 1956610.37% in 2020 and then plummeted by 1187267.58% in 2021.
- Mesoblast's Operating Income (Quarter) stood at -$734.6 million in 2019, then skyrocketed by 101.37% to $10.0 million in 2020, then tumbled by 9855.66% to -$978.4 million in 2021, then rose by 15.18% to -$829.8 million in 2022, then soared by 458.51% to $3.0 billion in 2023.
- Its Operating Income stands at $3.0 billion for Q2 2023, versus -$1.2 billion for Q1 2023 and -$829.8 million for Q4 2022.